Literature DB >> 16095148

Hyper-IgM1 syndrome with interstitial pneumonia and diarrhea caused by coxsackievirus B4 in a 3-month-old infant.

Sheng-Chieh Lin1, Shyh-Dar Shyur, Yi-Chun Ma, Li-Hsin Huang, Wen-I Lee.   

Abstract

BACKGROUND: Hyper-IgM1 syndrome is a rare genetic primary immunodeficiency disease caused by mutations of the CD40 ligand gene. It is characterized by normal or elevated levels of IgM and markedly decreased serum IgG, IgA, and IgE levels. Patients with this syndrome often easily develop infections. During the past decade, it has become clear that enteroviral infections may also occur as a manifestation of hyper-IgM1 syndrome.
OBJECTIVE: To report a case of hyper-IgM1 syndrome in a 3-month-old boy who had interstitial pneumonia and intractable diarrhea.
METHODS: Chest radiography, bronchoscopy, immune studies, and open lung biopsy were performed.
RESULTS: Chest radiography revealed diffuse bilateral infiltrates. Immune studies revealed the following proportions of lymphocyte markers: CD3, 5,976/microL; CD4, 5,015/microL; CD8, 866/microL; CD19, 1,325/microL; CD16 + 56, 935/microL; and active T cells, 225/microL. The IgG level was 190 mg/dL; IgA, 2 mg/dL; IgM, 34 mg/dL; IgE, 1 IU/dL; and CH50, 23.8/mL. CD40L expression was less than 1%, and a Tyr 169 Asn (t526a) mutation in the exon 5 tumor necrosis factor domain of the CD40L gene was found. The patient was treated with intravenous immunoglobulin and had a dramatic improvement in symptoms. Open lung biopsy failed to demonstrate pneumocystis, and there was no evidence of cryptosporidium in the stool. However, coxsackievirus B4 was isolated by viral throat culture.
CONCLUSION: Interstitial pneumonia and diarrhea caused by coxsackievirus B4 may be a complication of hyper-IgM1 syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095148     DOI: 10.1016/S1081-1206(10)61194-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

Review 1.  Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.

Authors:  A Heinold; B Hanebeck; V Daniel; J Heyder; T H Tran; B Döhler; J Greil; F-M Müller
Journal:  Infection       Date:  2010-10-28       Impact factor: 3.553

2.  Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan.

Authors:  Wen-I Lee; Tang-Her Jaing; Meng-Ying Hsieh; Ming-Ling Kuo; Syh-Jae Lin; Jing-Long Huang
Journal:  J Clin Immunol       Date:  2006-05-16       Impact factor: 8.317

Review 3.  Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection.

Authors:  Rajesh Kumar; Tripti Shrivastava; Sweety Samal; Shubbir Ahmed; Hilal Ahmad Parray
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-19       Impact factor: 4.813

4.  Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies.

Authors:  Denis Malvy; Khaled Ezzedine; Maria Mamani-Matsuda; Brigitte Autran; Hugues Tolou; Marie-Catherine Receveur; Thierry Pistone; Jérome Rambert; Daniel Moynet; Djavad Mossalayi
Journal:  BMC Infect Dis       Date:  2009-12-10       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.